ID3.md
... ...
@@ -2,6 +2,8 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @richterRecurrentMutationID32012, @spinaGeneticsNodalMarginal2016, @schmitzBurkittLymphomaPathogenesis2012
5 7
---
6 8
[[_TOC_]]
7 9
... ...
@@ -13,11 +15,7 @@ The existence of mutations in DLBCL were described in 2012 by Schmitz et al[@sch
13 15
14 16
## Relevance tier by entity
15 17
16
-|Entity|Tier|Description |
17
-|:------:|:----:|-----------------------------------------|
18
-|![BL](images/icons/BL_tier1.png) |1 | high-confidence BL gene [@richterRecurrentMutationID32012]|
19
-|![MZL](images/icons/MZL_tier1.png) |1 | high-confidence MZL gene [@spinaGeneticsNodalMarginal2016]|
20
-|![DLBCL](images/icons/DLBCL_tier2.png) |2 | Although recurrent, the relevance of mutations in DLBCL is tenuous[@schmitzBurkittLymphomaPathogenesis2012]|
18
+[[include:table1_ID3]]
21 19
22 20
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 21